Xponance, Inc. Inari Medical, Inc. Transaction History

Xponance, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$48.3 - $68.06 $1,255 - $1,769	26 Added 0.35%	7,531 $488,000
Q3 2023 Oct 23, 2023	SELL	$54.2 - $71.67 $650 - $860	-12 Reduced 0.16%	7,505 $490,000
Q2 2023 Jul 13, 2023	SELL	$56.23 - $71.17 $16,194 - $20,496	-288 Reduced 3.69%	7,517 $437,000
Q1 2023 Apr 17, 2023	BUY	$53.43 - $68.12 $1,656 - $2,111	31 Added 0.4%	7,805 $481,000
Q4 2022 Jan 23, 2023	SELL	$61.23 - $83.62 $4,714 - $6,438	-77 Reduced 0.98%	7,774 $0
Q3 2022 Oct 24, 2022	BUY	$65.58 - $84.69 $122,109 - $157,692	1,862 Added 31.09%	7,851 $571,000
Q2 2022 Aug 02, 2022	BUY	$52.13 - $93.81 $312,206 - $561,828	5,989 New	5,989 $407,000

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.77B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.